Product analysis: the device was discarded; therefore, no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Based on the received information, patient outgrowth was a factor for this event.The reported calcification could have caused the stenosis and high gradients.Calcification is an inherent risk of surgical valve replacement.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that approximately six years following the implant of this transcatheter pulmonary bioprosthetic valve, the valve was explanted after an echo showed severe pulmonary valve stenosis with increased gradients.The physician related the explant to both outgrowth and valve deterioration.The valve was reported to be stenosed and calcified.Subsequently, a non-medtronic valve was implanted.No additional adverse patient effects were reported.
|